Corporation , the global leader in consumer transaction technologies,
today announced that Shanghai
Anmao Information Technology Company is installing the NCR RealPOS TM
40 solution for the No.1
People’s Department Store of Zhangjiagang City Co., Ltd in Hangzhou.
Cowen Group, Inc. (“Cowen”) (NASDAQ:COWN) today announced the formation
of an information and technology services investment banking group and
the appointment of Davies Beller and James Kissane as Managing Directors
and Co-heads of the new group.
By Carla Mozee, MarketWatch
LONDON (MarketWatch) -- U.K. stocks climbed Wednesday, pushing to session highs alongside a broader rally among European stocks as investors bet on further stimulus measures from the European Central Bank.
Amber Road, Inc. (NYSE: AMBR), a leading provider of global trade
management (GTM) solutions, today announced that Chief Executive
Officer, Jim Preuninger, and Chief Financial Officer, Thomas Conway,
will present at the Needham Growth Conference in New York City on
January 13, 2015 at 2:50 p.m. ET.
Sign-up for 2015/1/7 - Lake Shore Gold Reports Record Production of 185,600 Ounces in 2014, Company Repays $45 Million of Debt and Increases Cash and Bullion to Approximately $60 Million investment picks
Multiple Microcyn®-Based Dermatology Products for Management of Pain/Itch and Scar Management Now Commercialized in the United States Four New Dermatology Products for Management of Scars, Atopic Dermatitis and Mild-to-Moderate Acne Now Commercialized in Europe
PETALUMA, Calif., Jan.
Starbucks Corporation (NASDAQ: SBUX) plans to release its first quarter
fiscal 2015 financial results after the market close on Thursday,
January 22, 2015, with a conference call to follow at 2:00 p.m. PT.
Generic biotech drugs took one step close to reality after a Food and Drug Administration advisory panel recommended the agency approve a Novartis AG (NVS) version of Amgen's Inc.'s (AMGN) drug Neupogen, according to media reports late Wednesday.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.